Anzeige
Mehr »
Login
Samstag, 25.05.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
Achtung! Ist das die Krypto-Aktie des Jahres 2024 mit 700% Potential?!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A1XCTC | ISIN: US74373P1084 | Ticker-Symbol: N/A
Stuttgart
20.10.23
14:55 Uhr
0,045 Euro
0,000
0,00 %
1-Jahres-Chart
PROVECTUS BIOPHARMACEUTICALS INC Chart 1 Jahr
5-Tage-Chart
PROVECTUS BIOPHARMACEUTICALS INC 5-Tage-Chart

Aktuelle News zur PROVECTUS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
14.05.PROVECTUS BIOPHARMACEUTICALS, INC. - 10-Q, Quarterly Report1
29.04.PROVECTUS BIOPHARMACEUTICALS, INC. - 10-K/A, Annual Report1
16.04.PROVECTUS BIOPHARMACEUTICALS, INC. - 8-K, Current Report-
28.03.PROVECTUS BIOPHARMACEUTICALS, INC. - 10-K, Annual Report1
27.03.Provectus Biopharmaceuticals Inc.: Provectus Biopharmaceuticals Announces Exclusive Worldwide License Agreement with University of Miami for Photodynamic Antimicrobial Treatment of Different Eye Infections with Rose Bengal Sodium65New Provectus Spinout Company Would Commercialize Combination Therapy of University's Light Source Medical Device and Provectus's Pharmaceutical-Grade Rose Bengal Sodium KNOXVILLE, TN, March 27,...
► Artikel lesen
26.03.PROVECTUS BIOPHARMACEUTICALS, INC. - 8-K, Current Report1
12.03.Provectus Biopharmaceuticals Inc.: Provectus Biopharmaceuticals Announces Notices of Allowance and Award for U.S. Patents of Rose Bengal Sodium in Virology, Pediatric Solid Tumor Cancers, and Vaccines233KNOXVILLE, TN, March 12, 2024 (GLOBE NEWSWIRE) -- Provectus Biopharmaceuticals, Inc. ("Provectus" or the "Company") (OTCQB: PVCT) today announced that the United States Patent and Trademark Office...
► Artikel lesen
22.02.PROVECTUS BIOPHARMACEUTICALS, INC. - 8-K, Current Report3
15.02.PROVECTUS BIOPHARMACEUTICALS, INC. - 8-K, Current Report2
15.02.Provectus Biopharmaceuticals Inc.: Provectus Biopharmaceuticals Announces First Quarter 2024 Conference Call3
18.12.23Provectus Biopharmaceuticals Inc.: Provectus Biopharmaceuticals Announces Notice of Allowance of First U.S. Patent of Rose Bengal Sodium for Use as Anticancer and Antiviral Vaccine Adjuvant196KNOXVILLE, TN, Dec. 18, 2023 (GLOBE NEWSWIRE) -- Provectus (OTCQB: PVCT) today announced that the United States Patent and Trademark Office (USPTO) has allowed patent application 17/488,430, titled...
► Artikel lesen
15.11.23Provectus Biopharmaceuticals Inc.: Provectus Biopharmaceuticals Provides Updated Data on Cancer Immunotherapy PV-10 for Advanced Cutaneous Melanoma345KNOXVILLE, TN, Nov. 15, 2023 (GLOBE NEWSWIRE) -- Provectus (OTCQB: PVCT) today provided updated data from an ongoing Phase 1b/2 clinical trial of investigational cancer immunotherapy PV-10 (rose bengal...
► Artikel lesen
13.11.23Provectus Biopharmaceuticals Inc.: Provectus Biopharmaceuticals Provides Updated Data on Cancer Immunotherapy PV-10 for Metastatic Uveal Melanoma538KNOXVILLE, TN, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Provectus (OTCQB: PVCT) today provided updated data from an ongoing Phase 1 clinical trial of investigational cancer immunotherapy PV-10 (rose bengal...
► Artikel lesen
28.06.23Provectus Biopharmaceuticals Inc.: Provectus Biopharmaceuticals Establishes Research Collaboration with University of Tennessee College of Veterinary Medicine to Investigate Pharmaceutical-Grade Small Molecule Immunotherapy Rose Bengal Sodium for Canine S215KNOXVILLE, TN, June 28, 2023 (GLOBE NEWSWIRE) -- Provectus (OTCQB: PVCT) today announced that the Company has initiated a new sponsored research program with the University of Tennessee College of...
► Artikel lesen
26.06.23Provectus Biopharmaceuticals Inc.: Provectus Biopharmaceuticals Announces Stockholder Approval to Undertake Reverse Split of Outstanding Equities and Reduce Number of Authorized Equities by Same Ratio329KNOXVILLE, TN, June 26, 2023 (GLOBE NEWSWIRE) -- Provectus (OTCQB: PVCT) today announced that the Company's shareholders have approved the proposals of Provectus's Board of Directors (Board) to seek...
► Artikel lesen
15 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1